Digestive comfort
Japanese clinical work supports zinc carnosine for gastric ulcer, where it is licensed, and a small Western trial showed it reduced the rise in small bowel permeability caused by a non-steroidal anti-inflammatory drug. Outside those settings the evidence for general digestive complaints is thin.
What may be going on: The intact complex adheres to ulcerated mucosa and has been reported to stabilise membranes and support mucosal repair, effects not reproduced by zinc salts alone.
Limited evidence. Early human work, or mostly lab and animal research.
View the 4 sources
- Efficacy and safety of polaprezinc in the treatment of gastric ulcer: A multicenter, randomized, double-blind, double-dummy, positive-controlled clinical trial.(opens in a new tab)
Randomised controlled trial · Medical engineering & physics · 2022 · PMID 35999163
- Efficacy and Safety of Polaprezinc-Based Therapy versus the Standard Triple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.(opens in a new tab)
Meta-analysis · Nutrients · 2022 · PMID 36235778
- Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial.(opens in a new tab)
Randomised controlled trial · PloS one · 2017 · PMID 28407007
- Zinc carnosine works with bovine colostrum in truncating heavy exercise-induced increase in gut permeability in healthy volunteers.(opens in a new tab)
Randomised controlled trial · The American journal of clinical nutrition · 2016 · PMID 27357095
Deep research mode adds each paper’s own conclusion and stated limitations.